TechCrunchLean L·
Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation
The de-extinction startup is looking to double or triple its previous valuation, according to the report.
Read at TechCrunch →
EngadgetLean L
The de-extinction startup is looking to double or triple its previous valuation, according to the report.
<iframe src="https://statesidedaily.com/embed/cluster/f16d98f199d3797bc8e60ca5d7f3eca83dfd3aac" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation"></iframe>